Cyclin-dependent kinase inhibitors move into Phase III
β Scribed by Guha, Malini
- Book ID
- 118049553
- Publisher
- Nature Publishing Group
- Year
- 2012
- Tongue
- English
- Weight
- 109 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1474-1776
- DOI
- 10.1038/nrd3908
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recent research has yielded a dramatic increase in the number of connections between oncogenesis and the proteins which regulate the cell cycle. Three classes of protein which inhibit the activity of cyclin-dependent kinases (CDKs) have emerged as potential targets for oncogenic inactivation. p16 an
## Abstract Cyclin dependent kinases (Cdks) are essential enzymes for the control of cell cycle progression. Inhibitors of cyclinβdependent kinases are anticipated to possess therapeutic utility against a wide variety of proliferative diseases, especially cancer. The field of published small molecu